Transplantation with bone marrow stromal cells promotes wound healing under chemotherapy through altering phenotypes

International Journal of Biological Sciences

Volumn 7, Issue 7, 2011, Pages 912-926

  Hu, Gang ^a   Liu, Peng ^b,c   Feng, Jie ^a   Jin, Yan ^b  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Military Hospital of PLA   (China)

Author keywords

Bone marrow stromal cells; Cell function; Cyclophosphamide; Delayed wound healing

Indexed keywords

MUS;

EID: 80052737451     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.912     Document Type: Article

References (23)

1. Guillot B, Bessis D, Dereure O. Mucocutaneous side effects of antineoplastic chemotherapy. Expert Opin Drug Saf. 2004; 3(6): 579-87.
2. Springfield DS. Surgical wound healing. Cancer Treat Res. 1993; 67: 81-98.
3. Shigeoka Y, Shimizu E. Myelosuppression due to antineoplastic agents. Nippon Rinsho. 2007; 65 (Suppl 8): 287-93.
4. Hawkins DS, Felgenhauer J, Park J, et al. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Cancer. 2002; 95(6): 1354-65.
5. Laurence V, Pierga JY, Barthier S, et al. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor. Am J Clin Oncol. 2005; 28(3): 301-9.
6. Feinstein L, Sandmaier B, Maloney D, et al. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cyto-toxic therapy by the graft-versus-tumor effect. Ann N Y Acad Sci. 2001; 938: 328-37.
7. Khouri IF, Saliba RM, Giralt SA, et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood. 2001; 98(13): 3595-9.
8. O'Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18(6): 853-75.
9. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol. 2003; 1(4 Suppl 2): 18-24.
10. Arnesen SM, Lawson MA. Age-related changes in focal adhe-sions lead to altered cell behavior in tendon fibroblasts. Mech Ageing Dev. 2006; 127(9):726-32.
11. Chodorowska G, Roguś-Skorupska D. Cutaneous wound healing. Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):403-7.
12. Lapidot T. Mechanism of human stem cell migration and re-population of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci. 2001 Jun;938:83-95.
13. Martin P, Leibovich SJ. Inflammatory cells during wound re-pair: the good, the bad and the ugly. Trends Cell Biol. 2005; 15(11): 599-607.
14. Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM. Wound healing: immunological aspects. Injury. 2006; 37 (Suppl 1): S5-12.
15. Teshima T, Ferrara JL. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol. 2002; 39(1): 15-22.
16. Sun Y, Tawara I, Toubai T, et al. Pathophysiology of acute graft-versus-host disease: recent advances. Transl Res. 2007; 150(4): 197-214.
17. Neal JW, Clipstone NA. Calcineurin mediates the calci-um-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J Biol Chem. 2002; 277(51): 49776-81.
18. Kim JE, Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes. 2004; 53(11): 2748-56.
19. Jager M, Schultheis A, Westhoff B, et al. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96). Anti-cancer Res. 2005; 25(2A): 947-54.
20. Fathke C, Wilson L, Hutter J, et al. Contribution of bone mar-row-derived cells to skin: collagen deposition and wound re-pair. Stem Cells. 2004; 22(5): 812-22.
21. Scimeca CL, Bharara M, Fisher TK, et al. Novel use of insulin in continuous-instillation negative pressure wound therapy as wound chemotherapy. J Diabetes Sci Technol. 2010;4(4):820-4.
22. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med. 2000; 6(4): 391-407.
23. Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002; 99(2): 157-6